Why the study?
Does statin treatment reduce cardiovascular risk in patients with rheumatoid arthritis?
Does statin treatment reduce cardiovascular risk in patients with rheumatoid arthritis?
While limited evidence suggests statins reduce cardiovascular risk in primary prevention for rheumatoid arthritis patients, further investigation is needed to determine if all RA patients benefit.
May support statin consideration for primary CV prevention in RA; leaves open confirmation in dedicated RCTs.
The published evidence shows that in RA patients statin treatment appears to reduce CV risk in primary prevention and that statin discontinuation is associated with an increased risk for CV events. However, the significance of statin treatment in RA patients still remains unclear as only very little evidence has been published. Whether all RA patients would benefit from treatment with statins still needs to be investigated.
No takes yet. Share an insight, caveat, or question.
Danninger et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: